• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌的组织学类型与诊断时的绝经状态无关。

The histological type of endometrial cancer is not associated with menopause status at diagnosis.

机构信息

The Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand.

Department of Gynaecology, The Hospital of Obstetrics and Gynaecology, Fudan University, Shanghai, China.

出版信息

Biosci Rep. 2022 Mar 31;42(3). doi: 10.1042/BSR20212192.

DOI:10.1042/BSR20212192
PMID:35237786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8935384/
Abstract

The latest evidence suggests that type 2 endometrial cancer may not be completely oestrogen-independent, indicating that the status of hormonal change may not be associated with the traditional classification of endometrial cancer, including the histological subtypes. However, this has not been investigated. Menopause is commonly considered a state of hormonal change in women. In the present study, we investigated the association of menopause with the histological types of endometrial cancer. Data on the histological type, menopause status at diagnosis, age at diagnosis, parity, body mass index (BMI), and overall survival rate from 2122 cases were collected. The difference in risk in developing type 1 or type 2 endometrial cancer between premenopausal and postmenopausal patients was 5.457%. A statistical difference in the association of menopause with the histological types between the two groups was seen in endometrioid and serous carcinoma, with a risk difference of 5.6 or 3.8%. A statistical difference in the association of menopause with parity between the groups was only seen in endometrioid and adenosquamous carcinoma, with a risk difference of 7.1 or 3.7%. However, BMI was not associated with histological type and the overall survival rate was not associated with menopause (P=0.764). We reported a relatively small difference in the association of menopause with type 1 or type 2, or the histological types of endometrial cancer. The survival rate was not associated with menopause. Our study suggests that menopause status at diagnosis was not strongly associated with the histological subtypes of endometrial cancer.

摘要

最新证据表明,2 型子宫内膜癌可能并非完全依赖于雌激素,这表明激素变化的状态可能与子宫内膜癌的传统分类无关,包括组织学亚型。然而,这一点尚未得到调查。绝经通常被认为是女性激素变化的状态。在本研究中,我们调查了绝经与子宫内膜癌组织学类型之间的关联。收集了 2122 例患者的组织学类型、诊断时的绝经状态、诊断时的年龄、产次、体重指数(BMI)和总生存率数据。绝经前和绝经后患者患 1 型或 2 型子宫内膜癌的风险差异为 5.457%。两组之间绝经与组织学类型之间的关联存在统计学差异,在子宫内膜样癌和浆液性癌中,风险差异为 5.6 或 3.8%。仅在子宫内膜样癌和腺鳞癌中,绝经与产次之间的关联存在统计学差异,风险差异为 7.1 或 3.7%。然而,BMI 与组织学类型无关,总生存率与绝经无关(P=0.764)。我们报告了绝经与 1 型或 2 型或子宫内膜癌组织学类型之间的关联存在相对较小的差异。生存率与绝经无关。我们的研究表明,诊断时的绝经状态与子宫内膜癌的组织学亚型没有很强的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ba/8935384/944c6f6eb6a3/bsr-42-bsr20212192-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ba/8935384/944c6f6eb6a3/bsr-42-bsr20212192-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ba/8935384/944c6f6eb6a3/bsr-42-bsr20212192-g1.jpg

相似文献

1
The histological type of endometrial cancer is not associated with menopause status at diagnosis.子宫内膜癌的组织学类型与诊断时的绝经状态无关。
Biosci Rep. 2022 Mar 31;42(3). doi: 10.1042/BSR20212192.
2
The pathogenesis of endometrial carcinomas at menopause: facts and figures.绝经后子宫内膜癌的发病机制:事实与数据。
J Clin Pathol. 2011 Jul;64(7):553-60. doi: 10.1136/jcp.2010.085951. Epub 2011 Feb 17.
3
Do obesity and age effect the clinicopathological features and survival outcomes in premenopausal women with endometrial cancer?肥胖和年龄是否会影响绝经前子宫内膜癌女性的临床病理特征和生存结果?
Eur J Gynaecol Oncol. 2016;37(3):320-6.
4
SPECIFICITIES OF ENDOMETRIAL PROLIFERATION/STEM CELL INDEX DISTRIBUTION IN ENDOMETRIOID CARCINOMA OF DIFFERENT GRADE OF MALIGNANCY.不同恶性程度的子宫内膜样癌中子宫内膜增殖/干细胞指数分布的特异性
Georgian Med News. 2018 Mar(276):117-123.
5
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.与高危型子宫内膜上皮癌相比,子宫内膜癌肉瘤具有不同的预后和扩散模式。
Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027.
6
Pathological findings in early-stage endometrial cancer.早期子宫内膜癌的病理检查结果
Eur J Gynaecol Oncol. 2003;24(1):18-20.
7
The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.组织学亚型在卵巢癌和子宫内膜癌发生发展中的影响:一项长期的全国性发病率研究。
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:17-22. doi: 10.1016/j.ejogrb.2017.12.014. Epub 2017 Dec 7.
8
Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause.在中国女性中,体重指数与子宫内膜癌呈正相关,尤其是在绝经前。
J Cancer. 2016 Jun 6;7(9):1169-73. doi: 10.7150/jca.15037. eCollection 2016.
9
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.PIK3CA 错义突变与 3 级子宫内膜样癌的不良预后相关,但与浆液性子宫内膜癌无关。
Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19.
10
Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.BRCA1 或 BRCA2 突变携带者的盆部高级别浆液性癌并非起源于子宫内膜。
Mod Pathol. 2013 Apr;26(4):572-8. doi: 10.1038/modpathol.2012.169. Epub 2012 Oct 19.

引用本文的文献

1
Immune microenvironment and molecular mechanisms in endometrial cancer: implications for resistance and innovative treatments.子宫内膜癌中的免疫微环境和分子机制:对耐药性及创新治疗的启示
Discov Oncol. 2025 Apr 16;16(1):532. doi: 10.1007/s12672-025-02169-z.
2
Prognostic significance of systemic inflammatory response markers NLR, PLR, and MLR in advanced high-risk endometrial cancer following radiotherapy.全身炎症反应标志物中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和单核细胞与淋巴细胞比值(MLR)在晚期高危子宫内膜癌放疗后的预后意义。
Am J Cancer Res. 2025 Mar 15;15(3):966-975. doi: 10.62347/YYNW9957. eCollection 2025.

本文引用的文献

1
Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.妊娠结局与子宫内膜癌风险:子宫内膜癌流行病学联盟个体参与者数据的汇总分析。
Int J Cancer. 2021 May 1;148(9):2068-2078. doi: 10.1002/ijc.33360. Epub 2020 Nov 17.
2
Age at Menopause and Risk of Developing Endometrial Cancer: A Meta-Analysis.绝经年龄与子宫内膜癌发病风险的关系:Meta 分析。
Biomed Res Int. 2019 May 29;2019:8584130. doi: 10.1155/2019/8584130. eCollection 2019.
3
International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.
国际子宫内膜癌发病率的模式和趋势,1978-2013 年。
J Natl Cancer Inst. 2018 Apr 1;110(4):354-361. doi: 10.1093/jnci/djx214.
4
The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer.1 型和 2 型子宫内膜癌的性激素水平并无差异。
Sci Rep. 2016 Dec 21;6:39744. doi: 10.1038/srep39744.
5
Obesity and Endometrial Cancer.肥胖与子宫内膜癌
Recent Results Cancer Res. 2016;208:107-136. doi: 10.1007/978-3-319-42542-9_7.
6
Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?1型和2型子宫内膜癌之间雌激素受体或孕激素受体的阳性情况是否不同?
Oncotarget. 2017 Jan 3;8(1):506-511. doi: 10.18632/oncotarget.13471.
7
Classification of endometrial carcinoma: more than two types.子宫内膜癌的分类:不止两种类型。
Lancet Oncol. 2014 Jun;15(7):e268-78. doi: 10.1016/S1470-2045(13)70591-6.
8
Past, present, and future of hormonal therapy in recurrent endometrial cancer.复发性子宫内膜癌激素治疗的过去、现在与未来
Int J Womens Health. 2014 May 2;6:429-35. doi: 10.2147/IJWH.S40942. eCollection 2014.
9
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.子宫内膜癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8. doi: 10.1093/annonc/mdt353.
10
Type I and II endometrial cancers: have they different risk factors?Ⅰ型和Ⅱ型子宫内膜癌:它们有不同的危险因素吗?
J Clin Oncol. 2013 Jul 10;31(20):2607-18. doi: 10.1200/JCO.2012.48.2596. Epub 2013 Jun 3.